Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 3
×
Everolimus
×
Gastrointestinal
×
Clear all
Filters
3
NCT05477576
2026-01-20
ACTION-1
RayzeBio, Inc.
Phase 3
Recruiting
288 enrolled
NCT04919226
2025-09-10
COMPOSE
ITM Solucin GmbH
Phase 3
Active not recruiting
259 enrolled
NCT01248403
2020-01-29
AIO-STO-0111
Krankenhaus Nordwest
Phase 3
Completed
300 enrolled
NCT01035229
2016-09-22
EVOLVE-1
Novartis
Phase 3
Completed
546 enrolled
18 charts
NCT00879333
2015-11-03
GRANITE-1
Novartis
Phase 3
Completed
656 enrolled
15 charts